This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

October 25-28, 2021
Delivered in a 100% Digital Format

Irina Tiper, PhD
Biologist at U.S. Food and Drug Administration


Dr. Tiper completed her PhD in Molecular Medicine at the University of Maryland, where she specialized in tumor immunology. She then completed a post-doctoral fellowship at the U.S. Food and Drug Administration, where she investigated application of novel bloodborne pathogen screening methods and antigenic drift in Ebola. She transitioned to regulatory work first as a Staff Fellow in the Office of Tissues and Advanced Therapies at the Center of Biologics Evaluation and Research (U.S. Food and Drug Administration) and then as a Biologist in the same office. Her review work is focused on immunotherapy, regenerative medicine, devices, and xenotransplanation. 

Agenda Sessions

  • KEYNOTE: Identification and Assessment of CQAs for Cell -based Therapies

  • Live Q&A with FDA

  • Live Q & A with Gaurav Agrawal, Joshua Tokuda, Julie Smith, and Sanjay Adhikari


Speakers at this event